Systems and methods for treatment of prostatic tissue

US2020205873A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2020205873-A1
Application numberUS-202016799039-A
CountryUS
Kind codeA1
Filing dateFeb 24, 2020
Priority dateNov 6, 2008
Publication dateJul 2, 2020
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.

First claim

Opening claim text (preview).

1 .- 15 . (canceled) 16 . A method of treating a disorder of a prostate, the method comprising: advancing a vapor ablation probe transurethrally into the prostate so that, within the prostate, the vapor ablation probe extends further in a longitudinal direction along a length of a urethra than in a transverse direction perpendicular to the longitudinal direction; delivering energy to the prostate via condensable vapor; and ablating a tissue of the prostate. 17 . The method of claim 16 , wherein the advancing the vapor ablation probe includes orienting a plurality of vapor ports of the vapor ablation probe toward the urethra. 18 . The method of claim 17 , wherein the delivering the energy includes delivering the condensable vapor toward the urethra. 19 . The method of claim 16 , wherein the advancing the vapor ablation probe includes advancing an introducer into the urethra and advancing the ablation probe through the introducer, and wherein at least part of the introducer and at least part of the ablation probe have complementary shapes preventing rotation of the ablation probe within the introducer. 20 . The method of claim 16 , wherein the vapor ablation probe has a curved shape. 21 . The method of claim 16 , wherein the advancing the vapor ablation probe includes advancing the vapor ablation probe from an apex of a lobe of the prostate toward a base of the lobe of the prostate. 22 . The method of claim 16 , wherein the delivering the energy includes delivering the condensable vapor in the transverse direction. 23 . The method of claim 16 , wherein the vapor ablation probe has a first portion, a second portion distal to the first portion, and a third portion distal to the second portion, and wherein, after the vapor ablation probe is advanced, each of the first portion and the third portion is closer to the urethra than the second portion is. 24 . The method of claim 16 , wherein the vapor ablation probe includes an electrode. 25 . A method of treating a disorder of a prostate, the method comprising: advancing a vapor ablation probe transurethrally into the prostate; delivering condensable vapor into the prostate via a plurality of vapor ports of the vapor ablation probe, wherein each of the plurality of vapor ports is oriented so as to deliver the condensable vapor toward a urethra; and ablating prostate tissue without ablating the urethra. 26 . The method of claim 25 , wherein the advancing step includes advancing the vapor ablation probe so that, within the prostate, the vapor ablation probe extends further in a longitudinal direction along a length of the urethra than in a transverse direction perpendicular to the longitudinal direction. 27 . The method of claim 25 , wherein the advancing step further includes advancing the vapor ablation probe into an apex of a lobe of the prostate and toward a base of the lobe of the prostate. 28 . The method of claim 25 , wherein the advancing step further includes advancing an introducer into the urethra and advancing the ablation probe through the introducer, and wherein at least part of the introducer and at least part of the ablation probe have complementary shapes preventing rotation of the ablation probe within the introducer. 29 . The method of claim 25 wherein the vapor ablation probe has a first portion, a second portion distal to the first portion, and a third portion distal to the second portion, and wherein, after the vapor ablation probe is advanced, each of the first portion and the third portion is closer to the urethra than the second portion is. 30 . The method of claim 25 , wherein the vapor ablation probe includes an electrode. 31 . A method of treating a disorder of a prostate, the method comprising: advancing a vapor ablation probe transurethrally into the prostate from an apex of a lobe of the prostate and toward a base of the lobe of the prostate so that, within the prostate, the vapor ablation probe extends further in a longitudinal direction along a length of a urethra than in a transverse direction perpendicular to the longitudinal direction; delivering condensable vapor into the prostate via a plurality of vapor ports of the vapor ablation probe, wherein each of the plurality of vapor ports is oriented so as to deliver the condensable vapor at least partially in the transverse direction; and ablating prostate tissue without ablating the urethra. 32 . The method of claim 31 , wherein the delivering the condensable vapor includes delivering the condensable vapor toward the urethra. 33 . The method of claim 31 , wherein the advancing the vapor ablation probe includes advancing an introducer into the urethra and advancing the ablation probe through the introducer, and wherein at least part of the introducer and at least part of the ablation probe have complementary shapes preventing rotation of the ablation probe within the introducer. 34 . The method of claim 31 , wherein the vapor ablation probe has a first portion, a second portion distal to the first portion, and a third portion distal to the second portion, and wherein, after the vapor ablation probe is advanced, each of the first portion and the third portion is closer to the urethra than the second portion is. 35 . The method of claim 31 , wherein the vapor ablation probe includes an electrode.

Assignees

Inventors

Classifications

  • in gaseous form · CPC title

  • Acoustic tracking systems, e.g. using ultrasound · CPC title

  • Irrigation · CPC title

  • Probes or electrodes therefor · CPC title

  • A61B18/04Primary

    by heating (by applying electromagnetic radiation A61B18/18) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2020205873A1 cover?
A prostate therapy system is provided that may include any of a number of features. One feature of the prostate therapy system is that it can access a prostate lobe transurethrally. Another feature of the prostate therapy system is that it can deliver condensable vapor into the prostate to ablate the prostate tissue. Methods associated with use of the prostate therapy system are also covered.
Who is the assignee on this patent?
Boston Scient Scimed Inc
What technology area does this patent fall under?
Primary CPC classification A61B18/04. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Thu Jul 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).